{"id":"NCT01305408","sponsor":"Cephalon","briefTitle":"Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder","officialTitle":"A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2013-07","completion":"2013-07","firstPosted":"2011-02-28","resultsPosted":"2015-01-26","lastUpdate":"2016-05-26"},"enrollment":399,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Depression"],"interventions":[{"type":"DRUG","name":"Armodafinil","otherNames":["Nuvigil","CEP-10953"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Armodafinil 150 mg/day","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to determine whether armodafinil treatment, at a dosage of 150 mg/day, is more effective than placebo treatment as adjunctive therapy to mood stabilizers for treatment of adults with major depression associated with bipolar I disorder.","primaryOutcome":{"measure":"Change From Baseline to Week 8 in the Total Score From the 30-Item Inventory of Depressive Symptomatology-Clinician-Rated (IDS-C30)","timeFrame":"Day 0 (baseline), Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-19.4,"sd":0.99},{"arm":"Armodafinil 150 mg/Day","deltaMin":-20.8,"sd":0.99}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2717"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":130,"countries":["United States","Argentina","Brazil","Bulgaria","Croatia","Finland","Germany","Hungary","Italy","Poland","Serbia","Slovakia","South Africa","Ukraine"]},"refs":{"pmids":["26330288"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":200},"commonTop":["Headache","Nausea"]}}